BSE: MANKIND - Mankind Pharma Limited
Yield per half year: -10.39%
Dividend yield: 0.00%
Sector: Healthcare
Reporting Mankind Pharma Limited
Share
IFRS
Annual
Quarterly
| 2023 | 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| EPS | 7.13 | 7.13 | 0.00 | |||
| Цена акции ао | 1983.05 | 2880.35 | 2201.1 | 2201.1 | 2354.83 | 3.54 |
Efficiency
IFRS
Annual
| 2023 | 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | 0 | -86.63 | ||
| ROCE, % | 0 | 0 | -23.18 | ||||
| Ebit margin, % | 0 | 0 | |||||
| Рентаб EBITDA, % | 0 | 0 | -31.98 | ||||
| Operation Margin, % | 0 | 0 | 0 | 0 | -90.75 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
